By analyzing MDS subtypes, we found the coexistence of signal pathway gene mutations (PTPN11 and NRAS) in MDS-AML patients, implying different functions of the same biological pathway genes in specific genomic contexts [21]. The gene discussed is NRAS; the disease is myelodysplastic syndrome.